News:
Our portfolio company, Curio Bioscience, is acquired by Takara!
Single-cell spatial profiling technology​
(Acquired by Takara)
Next-generation digital counting platform
Targeted therapies tackling drug resistance
Genetic medicine for autoimmune diseases